Once-weekly basal insulin is an option for selected adults with type 2 diabetes. Awiqli and Onswik are different products with different concentrations and transition schedules.
Call before traveling and name the exact service and location. Confirm the appointment, provider, records, tests, and medicine arrangements. A general walk-in visit does not guarantee a prescription, administration, specialist treatment, or a dietitian appointment that day.
Once-weekly basal insulin is an option for selected adults with type 2 diabetes. Awiqli and Onswik are different products with different concentrations and transition schedules. A supervised switch is essential.
Basal insulin provides background insulin action. Once-weekly products remain active for a long time, so dosing errors and low glucose can have prolonged effects. They do not automatically replace mealtime insulin.
The current US labels are for adult type 2 diabetes. Onswik is not recommended for type 1 diabetes because of severe low-glucose risk. Weekly treatment requires reliable monitoring and an ability to follow a product-specific weekly schedule.
Review current basal and mealtime insulin, glucose patterns, kidney function, and low-glucose history. Confirm access before changing treatment. The prescriber sets the initial and later doses, timing, and monitoring plan. Teach the exact pen and a written weekly record. Never calculate a conversion by multiplying the daily dose by seven yourself.
Bring insulin labels and devices, the exact daily regimen, meter or CGM report, kidney tests, and a record of lows. Describe work shifts, illness, or missed doses.
Do not use a concentrated pen as though it were another insulin. Never withdraw insulin from the pen into a syringe. Severe low glucose, accidental extra doses, or acute illness needs urgent advice. Keep existing insulin while awaiting a supervised switch.
Monitor more closely during a transition or dose change. Report lows promptly and keep a clear dose record. If the day or dose is uncertain, contact the clinician before another injection. A weekly schedule does not eliminate regular diabetes review.
Confirm the exact service, clinician, formulation, appointment, and refill route before booking. The evaluation, tests, medicine, administration, and follow-up may have separate costs and benefits. Ask for current estimates and required records. An FDA-approved drug or a clinic address does not establish pharmacy stock, onsite treatment, coverage, or a prescription. If access changes, contact the treating team before interrupting treatment.
Nao Medical Crown Heights: 341 Eastern Pkwy, Brooklyn, NY 11216. Call +1-917-310-3371 to confirm the specific service, clinician and appointment before travelling.
Contact the clinic to confirm this service, the clinician and appointment preparation. General clinic hours may differ from service appointment times.
Confirm the current address, hours, and appointment arrangements with Nao Medical before traveling. Mention the specific location and once-weekly basal insulin is an option for selected adults with type 2 diabetes. Ask whether records, tests, prescription review, training, or administration must be arranged ahead of time.
Call before traveling to confirm the exact service and appointment. An evaluation may require records, tests, or a later treatment decision. A general walk-in appointment does not guarantee medication, an injection, or specialist care that day. Bring insulin labels and devices, the exact daily regimen, meter or CGM report, kidney tests, and a record of lows. Describe work shifts, illness, or missed doses.
Bring insulin labels and devices, the exact daily regimen, meter or CGM report, kidney tests, and a record of lows. Describe work shifts, illness, or missed doses.
The current US Awiqli and Onswik indications are for adults with type 2 diabetes. Onswik is specifically not recommended for type 1 diabetes because of increased severe hypoglycemia risk. Do not replace a type 1 regimen with weekly insulin without specialist care.
No. Weekly insulin is basal or background treatment. Some people still need mealtime insulin or other diabetes medicines. The clinician reviews the whole regimen and glucose pattern before changing any part.
No. Initial switch doses, later weekly doses, timing, and monitoring differ by product and prior regimen. Multiplying the daily dose by seven yourself can cause dangerous low or high glucose. The prescriber must write the exact transition plan.
A weekly basal insulin may be self-injected after appropriate training when the prescription and care arrangement allow it. Confirm who teaches the exact pen and reviews glucose. Weekly dosing does not mean that no follow-up is needed.
If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact Sharad Suri at service@naomedical.com or by phone at (917) 633-1548 Extension 288. In our goal to answer your questions as quick as possible, we use the assistance of a large language model wherever applicable. If there are any errors or concerns, please bring it to our attention by emailing us.
Enter your phone number to begin scheduling your appointment.
You will be redirected to complete the appointment booking. Next: Book Appointment
Nao Medical will never sell your information to a third party.
Choose urgent care for a non-emergency illness or minor injury. For preventive visits and ongoing management, explore primary care at this location.
Visiting later? Review after-hours options and confirm clinic hours before traveling. For a life-threatening emergency, call 911.
(917) 310-3371
Facebook
Instagram
Twitter
LinkedIn
